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INTRODUCTION 
FNAC is the first choice for the initial investigation and diagnosis 
of both superficial and deep lesions though core needle biopsy is 
extremely valuable in selected cases. 
  FNAC is not only limited to neoplastic conditions, but FNAC is 
valuable in the diagnosis of inflammatory, infectious and degenerative 
conditions. 
 It is relatively painless and produces a speedy result. It is cost 
effective. Its accuracy in many situations can approach that of 
histopathology in providing an unequivocal diagnosis in the experienced 
hands. It is applicable when the lesions are easily palpable. 
The risk of needle tract seeding is extremely low, when truly fine 
needles of twenty two gauge or less are used. 
 The success of FNAC depends on the representativeness, 
adequacy of sample and high quality of preparation. 
At the community level, FNAC may be regarded as a simple 
screening test for serious disease, which needs further investigation and 
referral to a specialist 
 
3 
 
 
 
In the majority of the hospitals, it is an essential component of the 
final preoperative or pretreatment investigations on which the 
management of the problem is based. 
There would be little danger in extracting a small quantity of tissue 
from an obscure growth by the aid of a needle, trocar or cannula.So, little 
substance is necessary for the microscope that the diagnosis of cancer 
would no longer be equivocal or vague. 
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HISTORICALDEVELOPMENT 
At about the same time, histopathologist and cytologist began their 
tentative initiatives, Leyden and three years later, Menetrier employed 
needles to obtain cells and tissue fragments. 
In the UK in 1927, Dugeon and Patrick proposed the needling of 
tumours as a means of rapid microscopic diagnosis 
Similarly Martin and Ellis at memorial hospital in USA were also 
advocates of needle aspiration 
In Europe, particularly Scandinavia FNAC as a technique began to 
flourish in the 1950s and 1960s. 
Abulkasim an Arabian physician in the 10th century was credited 
for using the technique  
The earliest microscopist like Malphiggi and Virchow looked at 
scrapings and fluids under microscope and described their findings. 
In 1858 Rudolf Virchow published his cellular physiology, ward in 
1912, used FNAC to examine lymphnode for lymphoma 
Guthrie in 1921 first used lymph node aspiration on a systemic 
basis. 
In 1957 , Gibson & smith published their report on FNAC. At the 
radium hemmet in Stockholm about 12000 aspirations were performed 
every year, 2000 cases of thyroid alone .Other centres using this 
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technique on a large scale are the Harzen institute of oncology in Moscow 
and the Curie foundation at Paris. 
A current reliable view on FNAC of thyroid neoplasm has been 
published by Lowhagen et al 1979 and chu et al 1979. 
There is a large body of world literature showing to its accuracy 
and advantages, although the need of interpretation , meticulous attention 
to the technique and the limitations of diagnosis are well documented. 
Of many workers, it was Johanes Muller who set the foundation of 
clinical cytology. In 1938, he published on the nature and structural 
characteristic of the cancer and that morbid growth. 
In most hospitals in UK, the aspirations are performed by the 
clinicians, who send slides directly to the laboratory. As the equipment 
needed for FNAC is minimal, it can be performed in the clinic, ward or 
even in the patients home. In most cases, definite answer can be given 
and if a cytological diagnosis of malignant cell is made, histological 
diagnosis prior to treatment is not required. On the other hand a report of 
no malignant cells seen does not exclude cancer. 
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AIM OF THIS DISSERTATION 
 
1) To assess the cytological grading in fine needle aspiration 
cytology smears of common surgical swellings.  
2) To compare the cytological grade with a histopathological grade 
in surgical specimens and biopsies of common surgical 
swellings.  
 
The most common surgical conditions included in this study are 
 1. Salivary Gland Swellings 
 2. Lymph node Swellings 
 3. Thyroid Gland Swellings 
 4. Breast Lumps 
 5. Soft Tissue Swellings 
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METHODOLOGY 
Source of data  
Cytologically confirmed surgical swellings cases with respective 
specimens received in the department of pathology, THANJAVUR 
MEDICAL COLLEGE AND HOSPITAL, Thanjavur was studied over a 
period from August 2011 to Nov 2012.  
Materials  
1. Disposable hypodermic needles of size 23-24 and of length 
between 1-1.  Inches. 
2. Disposable sterile 5 ml syringe .The pistol syringe holder is 
preferred. But here it is not used 
 3. Swabs with spirit or skin sterilizing solutions. 
          4. Several 76 X 26 mm size microscope slides are suitably labeled               
and numbered 
5. Koplin jar for keeping the smeared slides in the fixative, the 
fixative being isopropyl alcohol. 
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FNAC apparatus 
 
 
 
 
 
 
                            Making slide 
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SAMPLE TECHNIQUE 
 
 The skin is cleaned and the lump is located. It is firmly held 
between the thumb and the forefinger of the free hand. The syringe is 
held by outside of the barrel and the needle tip is pushed into the lesion 
vertically. The plunger is partially retracted, creating a negative pressure, 
without loosening the pressure or pulling the needle tip out of the skin; 
the whole syringe is rotated by the movement of the wrist and gently 
moved out. The cutting edge of the needle tip frees the cells inside the 
lesion, which are sucked into the fine bore of the needle. 
 Using continuous negative pressure by pulling firmly on the 
plunger of the syringe, guide the cutting tip of the needle forwards and 
backwards obliquely through the firmly held lump and twisting the wrist 
to apply a rotating as well as forward and backward action, the cells are 
aspirated into the lumen of the needle. 
 Nothing is usually visible in the body of the syringe between the 
bottom of the plunger and the needle head, a cyst being an obvious 
exception.   
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Now, solely release the pressure on the plunger so that there is no 
more suction effect. Withdraw the syringe and needle gently from the 
skin. It is important, releasing of the pressure is not performed before 
removing the needle, and air will rush up the needle and loose the 
specimen onto the body of the syringe. 
 
EXPELLING THE BIOPSY MATERIAL 
 After the needle is withdrawn from the patient, it is removed from 
the syringe. The syringe filled with air and the needle is replaced firmly. 
Some workers using the air reservoir technique are not used here. 
 The syringe is held vertically with the needle tip above the surface 
of the microscopic slide, the plunger is pushed down and the contents of 
the needle are blown gently on the slide. 
 
MAKING OF THE SMEAR 
DIRECT SMEAR:  
 When the cells are adequate we can directly make the smear. 
 
INDIRECT SMEAR: 
 When the cells are inadequate, centrifuge the aspirates and then 
make the smear 
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HAEMATOXYLIN AND EOSIN STAINING FOR FNAC OF 
SWELLINGS. 
1. Cellular preparation is made rapidly as described above and with as 
minimal trauma to the cells. For fixation, the slides are immersed 
in 100% Isopropyl alcohol for a minimum of 30 minutes. 
2. The slides are then stained with Haematoxylin and left for 10 
minutes. 
3. The slides are washed in tap water and differentiated in acid 
alcohol. 
4. The slides are then left in running water till bluing. 
5. The slides are stained with Eosin for 2 minutes. 
6. Then the slides are washed, dried and mounted. 
 Two slides prepared for each case. 
 When aspirating the Thyroid, a vascular organ, a bloody aspirate is 
sometimes obtained. A technique similar to that of Karolinska 
Institute, Stockholm is used, the contents in the syringe are emptied 
rapidly on to one or 2 slides before the blood undergo clotting 
mechanism. There are semisolid contents on the slide, the spreader 
slide is turned over and the flat surface is pressed gently on to those 
small fragments and the slides pulled apart ending up with evenly 
spaced cells on both surfaces of the slide.  
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Methods of collection of data 
 The specimen of the swellings was fixed at 10% buffered formalin. 
Gross features were recorded. The specimens were processed and stained 
routinely with Hematoxylin and Eosin stain. Grading of these slides was 
done by the method of Nottingham modification of the Bloom 
Richardson method. Then the cytological grade was compared with the 
histological grade  
 
Statistical analysis:  
Data were analyzed by using Spearman’s correlation coefficient (r 
value) for correlation of cytological grading with histological grading. 
Also statistical test was applied to determine the p value to find the 
association between two grading systems.  
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REVIEW OF LITERATURE 
 
FNAC is not the substitute for histopathological examination. it is 
used in conjunction with clinical and radiological findings to provide best 
possible initial assessment on which management decisions can be based. 
 Team work careful technique and enthusiasm for fine needle 
aspiration cytology are essential factors while the organization of the 
work shold suit local conditions 
 
BREAST LUMPS 
In India breast cancer is the 2nd most common cancer among 
women after   carcinoma cervix. The incidence of the disease has shown a 
steep rise in women younger than 40 years of age. FNAC of the palpable 
breast lumps has become increasingly popular to diagnose any neoplastic 
conditions. FNAC provides a sensitive and economical method to obtain 
cytological material for assessment. Recently FNAC has largely replaced 
by excision biopsy. It allows conversation with the patient regarding 
various management plans for the neoplastic tissue on the same visit. 
FNAC is used in combination with clinical examination and radiological 
investigations like mammography. It is called “triple test” as diagnostic 
triad, which is a best method of analyzing the breast lumps.  
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     FNAC alone however is subject to faulty results and does not 
confirm identify breast lumps with the reliability of an excision biopsy. 
The aim of this study was to analyse our experience with FNAC in a 
group of patients with a palpable breast lump and compare the findings of 
FNAC with that of histopathology 
   Martin and Ellis, first reported the application of FNA in the 
diagnosis of palpable breast masses in 1930. In 1967 Zajicek et al 
published the fine needle aspiration experience of the Karolinska hospital 
group in Stockholm. Subsequently American institutions reported their 
experiences about FNAC of palpable breast lump. In 1984 Wanebo et al 
suggested FNA in place of an open surgical biopsy for the diagnosis of 
breast malignancy. The value of the diagnostic triad of physical 
examination, mammography, and FNAC as a complementary procedure 
to evaluate breast lump is now well documented. 
   In another study, this was conducted in the surgery department 
at federal government service hospital, Islamabad from Oct 2000 to Mar 
2001, where comparative study of FNAC with open biopsy of breast 
masses was done over 50 patients. Of which 22 patients had malignant 
cytomorphological features (44%) and 28 had benign (56%). Fine needle 
aspiration cytology was able to detect 20 malignant lumps with sensitivity 
of 90.9%. All the biopsy specimens presented as malignant with 
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specificity of 100%. False positive results came as zero percent and false 
negative were 9.1percent. They finally concluded as fine needle 
aspiration cytology is simple, rapid, bearable, cosmetically tolerable, 
trustworthy and cost effective of decisive histology of breast lump. The 
absence of false positives confirmed its place not only as a 
complementary addition but also aalternate of open biopsy in the majority 
of the instances.  
      In another comparative study of FNAC and open biopsy in 
breast lumps conducted in Nishtar hospital, Multan, in the period of Oct 
2001 to Oct 2003. In malignant disease, the sensitivity of fine needle 
aspiration cytology was 85.29% with 100% specificity, 100% positive 
outcome and 98.79% negative outcome. They concluded as, aspiration 
cytology had good sensitivity and very high specificity. FNAC replaced 
the excision biopsy in majority malignant breast tumour. Although fine 
needle aspiration cytology is not as much of sensitive (80%) in benign 
diseases it is greatly specific (100%), so it helps to bring back confidence 
and relieves the patients anxiety.. 
Detection and diagnoses of the breast lump 
           The role of FNAC in the diagnoses of breast disease is concerned 
with the examination of cells seen in the nipple discharges and those 
aspirated from solid and cystic lesions using a fine needle. The former is 
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a well established diagnostic test for carcinoma of the larger ducts, with 
or without Paget’s disease of the nipple, presenting with a blood stained 
discharge, but aspiration cytology is a newer technique, which is now 
finding its place in the breast surgeon’s diagnostic armamentarium 
           In recent years, the place of the rapid frozen section in the 
diagnosis of breast cancer has become reduced and has been replaced by 
increasing emphasis on preoperative diagnosis using a combination of 
clinical examination, mammography and biopsy, using a wide bore 
needle or aspiration cytology using a narrow hypodermic needle with 
rather than attempt to combine tissue diagnosis and mastectomy at one 
operation. 
Biopsy of the breast lesion 
Following are the methods of biopsy  
1. Fine needle aspiration cytology (FNAC) 
2. Tru-cut biopsy  
3. Intraductal biopsy  
4. Smears of nipple secretion  
5. Incision biopsy  
6. Excision biopsy  
7. Biopsy of lesions of the nipple  
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Comparison of benign and malignant features in breast fine needle 
aspirates1 
 
Sl. No. Benign features Malignant features 
1.  Normal Cell Size Increased Cell Size 
2.  Good cell adhesion one to 
another Loss of adhesion 
3.  Uniformity of cells Pleomorphism 
4.  Rather coarse but regular 
nuclear chromatin. 
Finer, paler nuclear chromatin 
often with prominent nucleoli with 
punctate area of  pale staining with  
the nucleus sometimes called as  
“intranuclearodima” 
5.  Low cellularity High cellularity 
6.  Smooth nuclear membrane Jagged appearance of nuclear 
membrane. 
7.  
‘Sentinal cells’- presence of 
small bare nuclei that often 
aggregate in pairs and clusters 
as well as appear singly in 
benign lesions (numerous in 
fibroadenoma). 
Absence of such cells in 
carcinoma. 
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              Ductal carcinoma in situ 
 
 
                      Infiltrating carcinoma breast 
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Comparison of merits of surgical biopsy and aspiration cytology8 
Sl. 
No. 
 Surgical biopsy FNAC 
1.  Diagnosis Histopathological Cytopathological 
2.  Diagnostic Facility Narrow Broad 
3.  Anesthetic Yes No 
4.  Length of procedure >5min <5min 
5.  Report available 1 to 2 days 1 to 2 hours. 
6.  False positive None Very rare 
7.  False negative Few Some 
8.  Cost High Low 
9.  Specimen obtained In operating Theatre 
In outpatient 
department 
10. Trauma Yes Little if any 
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BENIGN BREAST DISORDERS CLASSIFICATION7 
1. ANDI 
 Cyclical nodularity and mastalgia 
 Cysts 
 Fibroadenoma 
2. Duct ectasia and periductal mastitis 
3. Pregnancy related  
 Galactocele 
 Puerperal abscess 
4. Congenital disorders 
 Inverted nipple 
 Supernumerary breasts 
 Non breast disorders 
 Tietze’s disease 
 Sebaceous cyst and other skin conditions 
 
Risk of future invasive breast carcinoma (2,11) 
1. No increase 
 Adenosis 
 Apocrine metaplasia 
 Cysts small or large 
 Mild hyperplasia 
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 Duct ectasia 
 Fibroadenoma 
 Fibrosis 
 Mastitis, inflammatory 
 Periductal mastitis 
 Squamous metaplasia 
2. Slightly increased (RR 1.5-2) 
 Moderate or florid hyperplasia 
 Duct papilloma with fibrovascular core 
 Sclerosing adenosis , well developed 
3. Moderately increased (RR 4-5) 
 Atypical hyperplasia, ductal or lobular. 
 
FOOTE AND STEWART CLASSIFICATION FOR INVASIVE 
BREAST  CANCER 
1. Pagets disease of the nipple 
2. Invasive ductal carcinoma 
              A. Adeno carcinoma with fibrosis 
              B. Medullary carcinoma 
              C. Mucinous carcinoma 
              D. Papillary carcinoma 
              E. Tubular carcinoma 
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3. Invasive lobular cancer 
4. Rare cancer – Adenoid cystic 
 Squamous cell 
 Apocrine 
 
TNM STAGING OF BREAST CANCER 
Tumour 
Tx - cannot be assessed 
T0 - no evidence of primary 
Tis - in situ cancer 
T1 - Tumour   < 2cm 
T2 - Tumour   2-5 cm 
T3 - Tumour    >5 cm 
T4 - any size invading skin or chest wall  
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Node 
Nx-  cannot be assessed 
N0   -  No regional node metastasis 
N1  -  mobile axillary nodes 
N2  -  fixed axillary nodes 
N3  -Ipsilateral supraclavicular nodes 
Metastasis 
Mx  -  cannot be assessed 
M0  -  No distant Metastasis 
M1  -  Distant metastasis 
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LYMPH NODE SWELLINGS 
Lymph nodes are the most common organs where FNAC is 
performed. The simple procedure of needle aspiration of lymph nodes 
dates back to 1904, when Greig and Gray were investigating cases of 
trypanosomiasis. Nearly two decades later, in 1921, Guthrie 
systematically performed FNAC of lymph node for diagnostic purposes. 
In 1930, Martin and Ellis published their experience with the technique. 
As a result of the pioneering work of Franzen et al (1960) and the 
widespread acceptance of the procedure, FNAC of lymph nodes have 
become a standard laboratory procedure. In 1925, manyconsultants at 
Memorial hospital in New York examined the use of smears from 
aspirated materials on a large scale. Stewart reported 2,500 cases. Since 
FNAC of lymph nodes has become increasingly accepted and has been 
described often in the literature. 
 William J Frable (1976) published his personal experience in 
doing thin needle aspiration cytology with 469 cases and inferred that the 
victory of the procedure depends upon cautious analysis of the tumour to 
be biopsied and consideration to the particulars outlined in processing the 
material and preparing the slides. 
Friedman et al (1980), described the cytological findings of 
Hodgkin lymphoma in fine needle aspiration smears. Levitt et al (1985) 
inferred that the immunologic markers microscopic appearance of the 
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aspirated material were trustworthy and reliable in differentiating 
malignant and benign lymphomas and in decisive the B-cell or T-cell 
nature of the course.  
George KT et al (1987) concluded that cytologic agreement was 
best for high grade lymphoma. 
Das Dilip K et al (1990) published articles depicting scope and 
limitations of FNAC in the diagnosis of Hodgkin’s lymphoma and its 
subtypes. They indicated that fine needle aspiration cytology  is useful 
not only in the diagnosis of Hodgkin’s lymphoma, but also for 
characterization of 3 of its major subtypes (the lymphocyte predominant, 
mixed cellularity and lymphocyte depletion forms)  
 
CYTOLOGY AND HISTOPATHOLOGY OF LYMPH NODE 
LESIONS: 
Principal lesions of lymph nodes35:- 
As described by Koss et al 1992, cytodiagnosis of lymph node aspirates 
can be grouped under three major categories – 
A) Benign lymphadenopathies 
B) Lymphomas 
C) Metastatic tumors 
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A) Benign lymphadenopathies : 
The following patterns are described under benign lymphadenopathies: 
a) Acute lymphadenitis 
b) Hyperplastic lymph nodes; 
- Follicular hyperplasia 
- Paracortical hyperplasia 
- Granulomatous lymphadenitis 
- Sinusoidal expansion 
Malignant lymphomas: 
The technique of FNAC has been used extensively for the 
diagnosis of non Hodgkin’s and Hodgkin’s lymphoma. Over the past 50 
years, several systems have been proposed to classify malignant 
lymphomas like: Rappaport (1966), Kiel (1967), Lukes& Collins (1974), 
the Working Formulation (1982). Revised European  American 
Classification of Lymphoid Neoplasms (REAL). In 1998, anworldwide 
group of hematopathologists and oncologists convened by the WHO 
reviewed and updated the REAL classification, thus creating the WHO 
classification of lymphoid neoplasms. This new classification is of great 
importance for Cytopathology as it markedly decreases the importance of 
histologic architecture in the classification of NHL and places most of the 
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emphasis on individual cell morphology coupled with immunophenotypic 
and clinical characteristics of the NHL  
 
WHO classification of lymphoid neoplasms: 
B-cell neoplasms : 
-Precursor B – cell lymphoblastic leukemia / lymphoma 
-Mature B – cell neoplasms 
• Chronic lymphocytic leukemia / Small lymphocytic 
lymphoma 
• B-cell Prolymphocytic leukemia 
• Lymphoplasmacytic lymphoma 
• Waldenstroms macroglobulinemia 
• Mantle cell lymphoma 
• Follicular lymphoma 
• Extranodal marginal B zone lymphoma (MALT lymphoma) 
• Nodal marginal zone lymphoma 
• Lymphomatoidgranulomatosis 
• Splenic marginal zone B-cell lymphoma 
• Hairy cell leukemia(HCL) 
• Diffuse large B-cell lymphoma 
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Subtypes: mediastinal large B-cell lymphoma (thymic), intravascular 
large B cell lymphoma, primary effusion lymphoma 
• Burkitt lymphoma/ leukemia 
• Plasma cell neoplasms 
--Plasmacytoma 
--Plasma cell myeloma(PCM) 
--Monoclonal immunoglobulin deposition diseases 
--Heavy chain diseases 
T cell and Natural Killercell neoplasms: 
- Precursor T cell lymphoblastic leukemia / lymphoma 
- Mature T cell & Natural Killer cell neoplasms : 
• T cell prolymphocytic leukemia 
• T cell  granular lymphocytic leukemia 
• Aggressive Natural Killer cell leukemia 
• Extra nodal Natural Killer / T cell lymphoma, nasal type ( 
Angiocentric lymphoma) 
• Mycosis fungoides(Sezary syndrome) 
• Angioimmunoblastic T  cell lymphoma 
• Primary cutaneous CD-30 positive T-cell 
• Peripheral T  cell lymphoma, unspecified 
• Adult T cell leukemia / lymphoma (HTLV 1) 
29 
 
• Anaplastic large cell lymphoma ( T & null cell types) 
• Lymphoproliferative disorders 
--Primary cutaneous anaplastic large cell lymphoma (C-ALCL) 
--Lymphomatoid papulosis 
--Borderline lesions 
• Subcutaneous panniculitis like T  cell lymphoma 
• Enteropathy type intestinal T cell lymphoma 
• Hepatosplenic v delta T cell lymphoma 
• Blastic NK cell lymphoma 
Hodgkin’s lymphoma (HL): 
-Nodular lymphocyte predominance HL 
-Classic HL classified as 
• Nodular sclerosis type 
• Mixed cellularity type 
• Lymphocyte rich type 
• Lymphocyte depletion type 
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Table A - Primary sites of neoplasms and common sites of lymph 
node metastases: 
 
Cervical group 
Upper aero digestive tract 
Thyroid 
Skin of face 
Supraclavicular group 
GIT 
Head and neck carcinomas 
Lung 
breast 
Prostate 
Renal 
Skin 
Ovary 
Mediastinal group Lungs 
Axillary group Breast Skin 
Pelvic group 
Uterine cervix 
Uterine body 
Prostate 
Inguinal group 
Skin 
Uterine cervix 
Vulva / perineum 
Anal canal or rectum 
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Principles of interpretation 
The basic principle behind the interpretation of fine needle 
aspiration cytology specimens is that the cytological sample reflects the 
cellular composition of the target tissue. Clinical history, method of 
fixation, morphology of cells and histological appearance of the area 
being sampled play a significant role in accurate interpretation. A good 
clinicopathological correlation by a healthy interdepartmental rapport 
improves the accuracy by FNAC. FNAC material contains samples from 
the lesion and not exfoliated cells. In addition to cells, a small tissue 
biopsy is included in net aspiration. This provides information about the 
structure of the lesion. FNAC fits into an intermediate sampling 
procedure between exfoliative cytology and surgical biopsy. 
Cytopathologists should be well versed with both Cytopathology 
and histopathology to interpret the morphological picture of the cells 
studied.  
 
Advantages and uses of FNAC 
i) It is a day care procedure, which is less laborious and cost effective. 
ii) No hospitalization or anesthesia is required. 
iii) It is safe, less traumatic and better tolerated by patients. 
iv) Rapidly instant reporting and repetitive if necessary. 
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v) Viral and fungal infections can be more precisely interpreted. 
vi) It procures enough cellular material for various auxiliary studies like 
DNA analysis, molecular study and IHC studies. 
vii) Useful in further management and diagnosis of particularly soft tissue 
      masses. 
viii) Confirmatory in certain disseminating cancers and metastatic 
deposits. 
ix) Diagnostic in superficial swellings, hence avoiding open biopsy. 
x) Better assessment of response to treatment and detection of recurrence. 
Complications 
Complications from FNAC is more of theoretical value rather than a 
reality 
Classification of cervical lymphadenopathy34  
1. Inflammatory  -  Reactive hyperplasia 
 2. Infective; 
   Viral  - Infectious mononucleosis, HIV 
   Bacterial - Streptococcus, Staphylococcus 
-       Actinomycosis 
-       TB 
-       Brucellosis 
Protozoan - Toxoplasmosis 
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3.Neoplastic  
Malignant  
 Primary – Lymphoma 
 Secondary – SCC,melanoma 
 Known primary 
 Occult primary 
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THYROID SWELLINGS 
The development of important scientific contribution in medicine 
requires both the elixir of time and synthesis of a number of observations. 
There are additional social and economic considerations that influence 
the ultimate acceptance of the medical facts and development of medical 
procedures. The history of aspiration biopsy was influenced by such 
factors. The roots of fine needle aspiration cytology can be traced to 
Scandinavian countries. 
The British Medical Journal “Lancet” reported the first use of 
aspiration in 1833 when, liver mass aspiration was performed. It is done 
at St. Bartholomew’s Hospital situated in London by Edward Stanley. 
The diagnosis of the liver mass was hydatid cyst not a tumour. 
The first report of the needle biopsy can be traced to the literature 
way back in 1847, where Kun has cited the description of the procedure 
as follows “on plunging into the tumors with needle has a small 
depression with cutting edges, and can remove a small amount of tissue 
and a microscopic examination can be practiced”  In the late 1920’s, 
through the efforts of Martin- a clinician, Stewart and Ewing - 
pathologists, the practice of the fine needle aspiration of the palpable 
lumps and tumors situated in deeper regions began at “Memorial 
Hospital” in New York. In all cases, an attempt was made to procure 
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adequate amounts of material, not only for cytological smears but also for 
the preparation of the cell block and histological sections. A standard 18G 
needle was used and local anesthesia was administered. They reported 65 
cases with 80 percent accuracy rate and stressed on convenience and 
rapid diagnosis. The same authors published a total series of 1,400 cases 
in 193424.  
In 1988, a new technique - non-aspiration fine needle cytology 
pioneered in France was applied to study the nodular thyroid disease by 
Santor JEC and Leiman G. This technique referred to as “capillary 
suction technique and cytopuncture” by French authors employ insertion 
of the fine needle syringe and eliminate active aspiration which is 
replaced by the principle of capillary suction of fluid or semisolid 
material into the thin channel of the needle. 
Frable WJ (1989) found small needles (25G) to be useful in FNAC 
of the thyroid nodules. He preferred plain slides for air dried smears, 
because the cells will not give good smears on the surface of the ice-
covered slides. frozen slides retained more amount of cells if the material 
contains blood, water or fat. He described the features which are well 
depicted in MGG and Papanicolaou stains. Colloid, fire flares and 
amyloid are well depicted in MGG stain and oncocytes, psammoma 
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bodies and nuclear characters are well depicted in Papanicolaou 
stain.(26,27) 
In 1998 Nagasimha T et al suggested morphometry to evaluate 
lesions arising from thyroid follicle. In this study circular rate was higher 
in adenoma group .circular rate was low in follicular carcinoma and 
adenomas. The group with follicular carcinoma group had a higher LS 
ratio than adenomatous goiter groups. 
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EMBRYOLOGY 
The thyroid is the first endocrine gland to appear in the embryo and 
can be recognized as early as 24 days of gestation. The development of 
the thyroid gland commences as a median endodermal down growth from 
the primitive pharynx between the first and the second pharyngeal pouch. 
This median anlage forms a hollow diverticulum which descends into the 
anterior neck maintaining its connection with the tongue by a narrow 
tube, the thyroglossal duct. The tip of the tubular duct bifurcates and 
subsequently the whole mass divide into a series of double cellular plates 
from which the isthmus and the lateral lobes of the gland are developed, 
reaching its final position anterior to the trachea at about 7 weeks of 
gestation. The thyroglossal duct usually disappears at this stage. But the 
remnants of the duct may persist at any level along its course and may 
later develop ectopic thyroid tissue and a median cyst. 
The original opening of the thyroglossal duct is represented by a 
vestigial pit “the foramen ceacum” of the tongue. The ultimobranchial 
body derived from the fourth and fifth pharyngeal complex fuses with the 
median thyroid anlage and becomes part of the thyroid, contributing to 
the lateral lobes. The C cell progenitors are derived from the neural crest. 
These cells move around to the ultimobranchial bodies prior to develop as 
thyroid gland.  
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By the 14th week, the gland consists of well developed follicles 
lined by follicular cells and contains thyroglobulin positive colloid in the 
lumen. True developmental anomalies of the thyroid are related to the 
migration of its median anlage. 
 
ANATOMY 
The thyroid gland has two lobes. It is an endocrine organ situated 
in the middle of the neck region, larynx and trachea anteriorly and weighs 
approximately 20- 25 g in adult. The lobes are connected by the isthmus 
which is a band of variable size, lying close to the ventral aspect of the 
trachea covering the 2nd, 3rd and 4th tracheal rings. Each lobe is about  
5 cms in length and extends from the oblique line of the thyroid cartilage 
to the 6th tracheal ring. It is invested by the pretracheal fascia which is 
firmly attached posteriorly to the 2nd to 4th tracheal rings. 
 The superior and inferior thyroid arteries originating from the 
external carotid arteries and the thyrocervical trunk respectively provide 
the blood supply. The superior and middle thyroid veins collect the blood 
from the thyroid gland and transport it into the EJV. The inferior thyroid 
vein drains into the brachiocephalic vein. 
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The thyroid is rich supply with lymphatic vessels. These vessels 
connect both the lobes through the isthmus. Lymph from the upper part of 
the gland reaches the upper deep cervical lymph nodes either directly or 
through the prelaryngeal nodes, from the lower part to the lower deep 
cervical nodes directly and also through pretracheal and paratracheal 
nodes. Lymphatic form a plexus through which it may pass in any 
direction and also drain to retropharyngeal and retroesophageal lymph 
nodes along the recurrent laryngeal nerve chain. 
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PHYSIOLOGY 
The thyroid gland functions primarily to produce the thyroid 
hormone for normal development of the brain and to regulate the 
intermediate metabolism of carbohydrates and proteins and the 
consumption of oxygen. Steps in the biosynthesis of thyroid hormones 
include the ingestion of iodine present in water and food, the 
concentration of iodide within the gland and the organification of iodide 
to iodine by iodide peroxidase and then iodine binds to tyrosine to form 
monoiodo and diiodotyrosine. The iodotyrosine residues are condensed to 
form the biologically active thyroid hormone T4 and T3. These are stored 
as thyroglobulin and are the main constituent of colloid. When the gland 
is stimulated to release thyroid hormones, the endocytosis of colloid and 
proteolysis of thyroglobulin by lysosomal enzymes occur and T3 and T4 
diffuse into the blood stream. 
 Thyroid hormone synthesis is regulated by TSH and TRH 
secretion. Calcitonin is a 32 amino acid peptide that is released from the 
thyroid when the plasma calcium levels are increased. The activity of the 
thyroid gland and its constituent hormones can be determined in the 
laboratory and the gland morphology can be studied by the radioisotope 
scan and ultrasonography. 
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CYTOLOGY 
The cytological interpretation depends on the combined evaluation 
of cellularity, low power architectural pattern of the tissue fragments, 
high power cytological feature and background characteristics. 
The accuracy of the diagnosis depends on the experience of the 
individual performing the test and interpreting the findings. By using the 
well-documented cytologic criteria, most diagnostic entities can be 
readily identified from cytology samples. Diagnostic errors were most 
commonly due to inadequate specimens and cystic lesions. Normal 
thyroid aspiration shows colloid and thyroid follicular cells20. 
Follicular cells 
Follicular cells are dispersed or in small clusters. Follicular 
epithelial cells are fragile, the cytoplasm of the cells which is disrupted 
appear as empty nuclei. Bare nuclei are usually of similar size and the 
appearance similar to a normal lymphocyte. The cells are small with 
regular oval nuclei. The nuclear chromatin is finely granular and evenly 
dispersed or compact. The follicular cells has deep blue intracytoplasmic 
“paravacuolar granules”. The normal follicle may be seen in a cross 
section or Enface or in its entirety as a three dimensional structure. The 
follicle is comprised of cuboidal cells with regularly spaced small nuclei - 
7 to 9 µm in diameter with appreciable pale cytoplasm arranged around a 
lumen with or without  
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                 papillary carcinoma thyroid 
 
 
 
 
 
                       follicular adenoma 
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colloid. The cell borders may or may not be well defined. When 
aspirated in a sheet, the nuclei looks like honeycomb pattern. 
Occasionally whole follicle may appear as a pseudogiant cell. 
 
C Cells 
C cells resemble medullary carcinoma cells but are difficult to find 
in thyroid smear without resorting to immunostaining for calcitonin.  
 
Colloid 
Colloid from the normal thyroid is not ordinarily observed. Colloid 
has different staining qualities depending on the method of fixation and 
type of stain. In air dried Romanowsky stained preparation, colloid stains 
deep magenta. In pap smears the colloid stains from pale green to orange 
pink often with cracking artifact and clumping. Colloid stain pink in 
alcohol fixed H & E stain. Colloid may be washed off the slide during 
processing but parched earth or crazy pavement artifact may remain on 
the slide to sign the presence of colloid. Thicker colloid presents as dense 
clumps and globules. 
Extraneous cells can be obtained by the passage of the needle 
through strap muscles of the neck or sternocleidomastoid muscle. 
Puncture of the trachea yields respiratory epithelial cells, mucous and 
occasionally fragments of cartilage.  
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Adipose tissue is not usually obtained except in the very obese 
although there are other possibilities like lipoma of the neck, thyrolipoma 
and adipose metaplasia in a nodular goiter. 
There is no contraindication to the needle aspiration of the thyroid 
swellings 
Complications 
1 The major complication is the hemorrhage and hematoma 
formation. This occurs mainly in patients with large goiter or in 
malignancy. This may cause discomfort but dissipates 
spontaneously. 
2 Accidental carotid artery puncture requires to occlude the puncture 
site for five minutes. 
3 Temporary laryngeal nerve paresis. 
4  Puncture of trachea. This can cause a coughing spasm and small 
amounts of blood may be coughed up but recovery occurs within a 
few minutes. 
5 Hemorrhage, necrosis or infarction caused by FNAC may 
occasionally obscure the histological pattern of the thyroid 
neoplasms. 
6 Occasionally implantation in the needle track following FNB has 
been reported. 
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7 To prevent from these complications ,USG guided FNAC is very 
useful and sensitive tool to diagnose thyroid lesions 
Principle lesions of the thyroid gland that may be identified in 
aspiration cytology are as follows (Koss GL) 
1. Cysts 
2. Colloid goiter (adenomatous / diffuse / nodular) 
3. Thyroiditis – acute, subacute, lymphocytic / autoimmune 
4. Adenoma 
5. Carcinoma 
i. Papillary carcinoma and its variants 
ii. Follicular neoplasm 
iii. Medullary carcinoma 
iv. Anaplastic carcinoma 
a. Large cell 
b. Small cell 
6. Malignant lymphomas 
7. Metastatic tumors 
 
 
 
 
 
46 
 
CLASSIFICATION OF THYROID SWELLINGS30: 
1. Simple goiter (Euthyroid) 
2. Diffuse hyperplastic 
3. Physiological 
4. Pubertal 
5. Pregnancy 
6. Multi nodular goiter 
7. Toxic 
 Diffuse-Grave’s 
 Multinodular 
 Toxic Adenoma 
8. NEOPLASTIC 
 Benign   
 Malignant 
9. Inflammatory: 
 Autoimmune-Chronic lymphocytic thyroiditis ,Hashimotos’s 
thyroiditis 
 Granulomatous -De Quervain’s thyroiditis 
 Fibrosing -Ridel’s thyroiditis 
 Infective -Acute (bacterial, viral, subacute) 
 Chronic (TB, syphilitic) 
 Others- Amyloid. 
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CLASSIFICATION OF HYPOTHYROIDISM23 
Autoimmune thyroiditis (chronic lymphocytic) 
 Non goitrous       - Primary myxeodema 
 Goitrous              - Hashimoto’s 
Iatrogenic 
 After thyroidectomy 
 After radioiodine therapy 
 Drug induce (anti-thyroid, PAS & Iodines in excess) 
Dyshormonogenesis 
Goitrogens 
Secondary to primary or hypothalamic disease 
Thyroid agenesis 
Endemic Cretinism 
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CLASSIFICATION OF THYROID NEOPLASMS32: 
1. BENIGN 
 Follicular Adenoma 
2. Malignant 
     i) Primary 
 Follicular epithelium 
 Differentiated           - Follicular 
             - Papillary 
 Undifferentiated       - Anaplastic 
 Para follicular cells 
 Medullary 
 Lymphoid cells 
 Lymphoma 
ii) Secondary 
 iii) Metastatic 
 iv) Local infiltration 
 
TNM staging of thyroid cancer 
Tx    -   primary tumour cannot be assessed 
T0    -   no evidence of primary 
T1    -   limited to thyroid < 1cm 
T2    -   limited to thyroid > 4cm 
T3    -   limited to thyroid > 4cm 
T4    -   extending beyond the capsule, any size 
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NODES 
Nx   -   cannot be assessed 
N0   -   no regional nodal metastasis 
N1   -   regional nodal metastasis 
 
METASTASIS 
Mx  -   cannot be assessed 
M1  -   metastasis present 
CLASSIFICATION OF THY GRADING31 
• Thy1- Non Diagnostic 
• Thy2 - Nonneoplastic 
• Thy3 - Follicular 
• Thy4 - Suspicious Of Malignancy 
• Thy5 - Malignant 
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SOFT TISSUE TUMOURS 
Despite 2000 years of history of European medicine the first 
comparative description of sarcomas, called “encephaloid tumors” and 
carcinomas, called “scirrhous tumors” was done by Samuel Gross in 
1866. This classification was modified by James Ewing, pathologist at 
MemorialHospital for Cancer and Allied disease in New York  in 1919. 
Ewing’s classification system served as the basis for our present 
classification of sarcomas. 
Despite Carrel’s 1926 warning that “connective tissue cells must be 
defined not only by their morphology but also by their physiological 
properties”, mesenchymal cells and mesenchymal tumors have rarely 
been studied from any other point of view other than pure morphology. 
In 1976, Hajdu and Hajdu published the book known as 
Cytopathology of Sarcomas and other Nonepithelial Malignant tumors, 
which provided cytologic description of a large number of sarcomas. 
In 1986, Miralles et al reviewed 117 cases of soft tissue lesions, 
which included twenty three non-neoplastic lesions, 34 benign 
mesenchymal tumors and sixty histologically confirmed soft tissue 
sarcomas. The soft tissue sarcomas were classified according to their 
cytomorphology into five groups, based on histological diagnosis. These 
are 1.low grade sarcomas, 2.myxoidtumours, 3.monomorphictumours, 
4.round-celltumours and 5.pleomorphic sarcomas. Difficulties were 
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experienced in the correct assessment of aspirates from low grade 
malignancies but in high grade malignant sarcoma, Fine needle aspiration 
cytology was useful for both the initial diagnosis of a new lesion and in 
confirmation or elimination of a suspected treatment failure. He, 
however, concluded that the cytologic diagnosis on a FNA was not a 
substitute for the histological diagnosis on a tissue section and hence the 
final diagnosis of soft tissue sarcoma should be based upon the 
histological study. 
In 1992, Ricardo Gonzalez-Campora et al reviewed ninety eight 
cases of FNAC of soft tissue tumors with histological confirmation. They 
proposed a working morphological classification based on the most 
prominent cytological features and identified. They believed that this 
classification allows recognition of the most common soft tissue tumors 
while helping with the differential diagnosis of other neoplasia, primary 
or secondary, with similar morphology and presentation. 
In 2000, AnirbanMaitra et al studied 72 cases using fine needle 
aspiration cytology as a primary diagnostic modality for primary 
mesenchymal lesions.. Based on their study, FNAC gave excellent 
accuracy of 88%, sensitivity of 89% and specificity of 87% for 
classification. Their true positive cases were 24 / 72, true negative 39 / 
72, false positive 6 / 72 and false negative 3 / 72. the most common 
diagnostic category  were Spindle cell lesions .in these tumor entities, 
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granular cell tumor had the best cytohistological association with 100% 
correct identification on FNAB. 
TUMORS OF ADIPOSE TISSUE 
The first reference to adipose tissue tumors is in the Papyrus Ebers. 
It was written in 1552 B.C. The largest adipose tissue tumor was reported 
and illustrated in the Cleveland Medical Gazette in 1859. According to 
historians, Delameter travelled from Cleveland to Ohio and excised a 268 
pound tumor from a patient. The cell of origin of the fat cell was 
unknown. Ewing, in a lecture in 1935, said that “steatoblasts and 
lipoblasts are derived from the adventitial layers of blood vessels”. 
In 2002, KusumKapila et al analysed the cytology and histological 
features of benign and malignant tumours involving adipose tissue on 
FNA in 90 cases. They tried to determine if the variants of liposarcoma 
could be identified since only few reports were available describing the 
cytomorphology of lipomatous tumors. 
In the benign category the age between 12 and 18 years with a 
male : female ratio of 2:1, while in malignant lipomatous tumors, age 
varied from 12 to 77 years with a M;F ratio of 1.7:1. The diagnosis of a 
lipoma on FNAC could be made in conjunction with the clinical setting 
of a soft, subcutaneous lump with slipping margins on palpation. The 
aspirator’s opinion was important. The consistent cytomorphological 
features observed on FNAC were adipose tissue lobulation (73%) and 
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thin capillaries traversing the lobules of adipocytes (92%), with few being 
thick walled (65%). The diagnostic terms, atypical lipoma and atypical 
lipomatous tumors were used for liposarcoma and consisted of tumors at 
particular sites, such as deep seated tumors in the extremity. These 
tumors had a good prognosis. Well differentiated liposarcoma, posed a 
problem and only 4 to 8 histologically documented cases could be 
diagnosed by FNAC. The finding of an unequivocal lipoblast 
(univacuolated or multivacuolated) with scalloped nuclei was mandatory 
for the diagnosis. They concluded that FNAC could be a valuable 
diagnostic method in the preoperative conclusion of benign and 
malignant lipomatous tumors with further categorization of liposarcomas 
being possible, but not very reliable. 
In 1997, Stanislaw Woyke et al described atypical lipoma as a 
potential drawback in the cytological and histological diagnosis of 
subcutaneous tumors. Well-differentiated liposarcomas occurring in the 
subcutis behaved as benign neoplasms with an exceptionally rare 
tendency for differentiation, hence were termed, “Atypical lipoma” in 
1975. FNA of these subcutaneous tumors showed mature adipose tissue 
and small dispersed, hyperchromatic, often lobulated and bizarre nuclei 
that were usually stripped of cytoplasm. Only occasionally, was a wisp of 
pale, poorly preserved, vacuolated cytoplasm present. They concluded 
that before a cytodiagnosis of atypical lipoma is suggested, confirmation 
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by ultrasonography of the confinement of the tumor to subcutis was 
important, that in cytology reports the term lymphoma with atypical cells 
should be used for all these entities and that the final categorization 
should be left to histology. 
In 2001, Lourdes R. Ylagan and SanjeevBhalla described the 
dedifferentiation features of a well-differentiated liposarcoma of 
retroperitoneum and were the first to do so. Dedifferentiation meant a 
histologically changed into low grade to high grade. This event occurs 
inretroperitoneal tumors and who is taking treatment. The features of 
dedifferentiation could be towards any mesenchymal element present. In 
their study, using immunohistochemistry, they found the dedifferentiated 
components as fibrohistiocytic and leiomyosarcomatous. They concluded 
that the radiologic features of a neoplastic process could be very helpful 
in decisive the nature of the events. 
TUMORS OF SMOOTH MUSCLE 
In 1981, Ingvar Dahl et al made the first effort to correlate the 
cytology and histological features ofleiomyosarcoma of soft tissue with 
cytological and histological study of 11 cases. The leiomyosarcomas were 
identified morphologically by stretched out tumor cells arranged in 
bundles, criscrossing each other at wide angles. The nuclei were 
lengthened and often dull ended, aligned in position or in 
rows.Leiomyosarcoma smears were poor in malignant cells. Cells are 
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arranged in groups or singles. The characteristic dull ended nuclei, which 
were aligned in rows and in parallels, were identified. Nuclear atypia, 
although not very pronounced, permitted the diagnosis of malignancy. 
TUMORS OF SKELETAL MUSCLE 
In 1956, Riopelle and Theriaultanalysed a series of patients with “round-
cell sarcoma”, identified by peculiar pseudo-alveolar pattern and 
rhabdomyoblastic delineation. They selected the name ‘alveolar 
rhabdomyosarcoma’. 
In 1962, Patton and Horn used imprint cytology to study three 
cases of alveolar rhabdomyosarcoma and invented an undifferentiated 
representation.but did not mention on cellular details. 
In 2000, Henryk A. Domanski and Sigmund Dawiskiba reported 
two cases of adult rhabdomyomas by fine needle aspiration. The smears 
showed poorly cohesive cell clusters, single polygonal cells or syncytial 
cell groups with abundant granular, dense cytoplasm and distinctive 
cytoplasmic borders. The nuclei were round, small, uniform, usually 
located peripherally, with a regular chromatin pattern and frequent small 
nucleoli. Faint striations could be seen in the cytoplasm in some syncytial 
cell clusters. The background of the smears was bloody. 
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TUMORS OF PERIPHERAL NERVES 
Ancient neurilemmomas were described by Ackerman and Taylor 
in 1951. It is a cellular form of neurilemoma showing nuclear 
polymorphism and hyperchromasia. 
In 1984, Ingvar Dahl et al presented a correlative 
cytomorphological study of 28 cases of solitary neurilemomas. In the 
smears, the Antoni type A area was mentioned by fragments of tissues 
with a fibrillary ground material, spindle shaped cells forming Verocay 
bodies. The Antoni type B area was represented by wobbly microcystic 
materials with cells having lengthened nuclei, its look like fish-hooks, 
containing vague, slight, cytoplasmic processes. The ancient 
neurilemomas, a variant, were characterized both cytomorphologically by 
hyperchromatic nuclei and polymorphism. 
In 1999, Jose A. Jimenez–Heffernan et al reviewed 10 patients with 
malignant peripheral nerve sheath tumor (MPNST). Aspirates were 
divided into two groups, spindle and epithelioid. No morphological 
features were specific to MPNST. The only feature suggestive of nerve 
sheath differentiation is by presence of elongated, slender, often wavy 
nuclei and less commonly a delicate fibrillary metachromatic stroma. 
According to their study, the cellularity of the smears and the cellular 
dissociation along with clinicoradiologic information including the tumor 
location and size were of critical importance. 
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In 1999, Scheithauer et al differentiated neurothekeoma (NT) and 
nerve sheath myxoma (NSM) on the basis of histopathology, 
immunohistochemical and ultra structural findings. They consider NSM a 
multilobulated spindle cell neoplasm, predominantly myxoid, showing 
Schwann cell differentiation, while the term neurothekeoma was used for 
less myxoid and more cellular lesions with numerous epithelioid cells and 
lacking this phenotype. 
In 2003, Agustin VailloVinagre et al were the first to describe the 
cytologic features of neurothekeoma. The smears show increased amount 
of metachromatic, myxoidmatrix ,fusiform and epithelioid cells. these are 
binucleated or multinucleated, arranged loosely or in cluster and 
sometimes forming thick whorls. They concluded that the fusiform and 
epithelioid cells set in thick whorls in a myxoid lesions were the 
distinctive characteristics of this neoplasm which correlated well with 
histology. 
 
FIBROHISTIOCYTIC TUMORS 
In 1967, Stout and Lattes first introduced the term, “Malignant 
fibrous histiocytoma”. Various terms had been used for this neoplasm 
because of its uncertain histogenesis and morphological variations. 
Walaas et al, in 1986, in the largest series of study on malignant 
fibrous histiocytomas (MFH), described the cytologic features in 40 
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cases. This description included 2 main tumor types, one is atypical 
fibroblast like cells which is mononucleated or multinucleated, another 
one is large polymorphic histocyte like cells, with the later showing 
phagocytosis. 
 
 
TUMORS OF BLOOD AND LYMPH VESSELS 
In 1872, Moritz Kaposi, a Hungarian physician working in Vienna, 
gave the first account of angiosarcoma, which was later named after him.  
In 1943, A.P. Stout adopted the term hemangioendothelioma and 
employed the reticulin stain to give the classic description of the tumor. 
In 1999, Katharine Liu and Lester J. Layfield studied 11 aspirates 
of angiosarcoma. The aspirates were hypocellular. They proposed that 
when rare, single round, oval or spindle pleomorphic cells with unusual 
nuclei and pale, blue-gray, empty cytoplasm are identified in the 
environment of abundant blood and scattered inflammatory cells, the 
possibility of angiosarcoma should be raised. They stressed that the 
identification of intracellular hemosiderin deposits in these pleomorphic 
cells renders a definitive diagnosis of angiosarcoma. Furthermore, they 
concluded that it may be not possible to differentiate angiosarcoma from 
changes occur due to radiation. 
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In 1990, Kim R. Geisinger et al described the FNA feature of four 
cases of hemangiopericytomas (HPC). The aspirates were cellular and 
consisted of uninuclear tumor cells with high nuclear cytoplasmic ratio. 
The cytomorphological spectrum included nuclei that were oval to 
elongate and had very finely granular, evenly distributed chromatin with 
one or two small distinct nucleoli. High mitotic activity was noted in all. 
They analyzed that a diagnosis of hemangiopericytoma on FNA was 
unlikely. Cytomorphological evaluation may however allow diagnosis of 
recurrent or metastatic hemangiopericytoma. 
In 1999, David Chhieng et al reported 5 cases of 
hemangiopericytoma (HPC). They described that hemangiopericytomas 
appear as spindle cell appearance in cytologic preparations hence must be 
differentiated from  spindle cell lesions. branched capillaries and 
abundant basement membrane in histological smears rules out diagnosis 
of hemangiopericytoma. They postulated that IHC and electron 
microscopy shown on fine needle aspiration samples may be useful in 
differential diagnosis. They conclude that fine needle aspiration is useful 
and accurate to confirm frequent or metastatic hemangiopericytomas, 
however, the forecast of the biologic performance of 
hemangiopericytoma  based on cytologic features is not feasible. 
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TUMORS OF METAPLASTIC MESENCHYME 
In 1953, Stout and Verner first established the entity of 
extraskeletalchondrosarcoma. They concluded, that since the distribution 
of benign cartilaginous tumors and extra skeletal chondrosarcomas differ, 
it is probable that the latter arise de novo, rather than from preexisting 
chondromas. 
In 2002, Lakshmi Rao et al presented a case of extraskeletal 
myxoid chondrosarcoma affecting chest wall concealed as a lump arising 
from breast. On aspiration cytology the diagnosis was rendered as 
mucinous carcinoma or mixed tumor of the breast, but on frozen section, 
a conclusion of extraskeletal myxoid chondrosarcoma was made. They 
conclude, that when polygonal cells are seen in a myxoid / 
mucoidenvironment, the possibility of extraskeletal myxoid 
chondrosarcoma should be considered. 
TUMORS OF SYNOVIAL TISSUE 
In 1993, Seena C. Aisner et al quoted2 cases of synovial sarcoma. 
The first was in 15 year old female with aspiration cytology revealing 
numerous clusters of spindle cells admixed with small groups of 
epithelial cells. Cytokeratin and vimentin stains were positive in the 
epithelial and spindle components, respectively. Second, a 53 year old 
male presented with a recurrent synovial sarcoma with aspiration 
cytology revealing only neoplastic spindle cells. Cytokeratin and 
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vimentin preparations showed focal positivity. They concluded that FNA 
cytology could be useful in diagnosing both primary and recurrent 
synovial sarcomas of soft tissues with immunocytochemistry aiding in 
differentiating it from other malignant soft tissue tumors. 
TUMORS OF UNCERTAIN CELL TYPE 
In 2005, Paul E. Wakely et al studied 39 cases of myxoma /or juxta  
articularmyxoid lesion or ganglion (MJG) by reviewing all FNAB 
specimens. They concluded that FNA cytology diagnosis of MJG lesions 
can be highly accurate in distinguishing benign from malignant entity and 
also in subtyping them into 3 distinct categories of ganglion, juxtra-
articular myxoid lesion or intramuscular myxoma, when clinical and 
radiologic data was considered along with the cytopathologic features. 
Thus FNA biopsy deferred surgery unless clinical symptoms warranted 
surgical Intervention. 
Predisposing factors for sarcoma 
 Neurofibromatosis 
 Li-Fraumani syndrome 
 Retinoblastoma 
 Gardners syndrome 
 Radiation exposure 
• Ortho and mega voltage therapeutic radiation 
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 Lymphedema 
 Post surgical 
 Post irradiation 
 Parasitic infection (Filariasis) 
Trauma 
 Post parturition 
 Extremity 
 Chemical 
 2,3,7,8 – Tetrachlorobenzodioxin 
 Polyvinyl chloride 
 Hemochromatosis 
 Arsenic 
AJCC STAGING 
Primary tumour 
 T1 - Tumour< 5 cm 
  T1a - Superficial 
  T1b - Deep 
 T2 - tumour> 5 cm 
  T2a - superficial 
  T2b – deep 
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Regional lymph nodes 
 N0 - No regional nodal metastasis 
 N1 - Regional nodal metastasis 
Distant metastasis 
 M0 - No distant metastasis 
 M1 - distant metastasis 
Histological grade 
 G1 - Well differentiated 
 G2 - Moderately differentiated 
 G3 - Poorly differentiated 
 G4 - Undifferentiated 
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SALIVARY GLAND SWELLINGS 
 The salivary glands are not subjected to incisional or core needle 
biopsy because of the risk of fistula and in neoplasm for fear of tumor 
implant 
 More than 50% swellings are non neoplastic 
ACCURACY 
 From the Karolinskastudy , FNAC accuracy for salivary gland 
neoplasms are more than 90% 
 More than 90% of pleomorphic adenoma and most malignant 
tumours are diagnosed correctly 
 In a review in 1994, sensitivity was 81-100%, specificity was 94-
100% and accuracy of typing was between 61-80%  
 The heterogeneous structure of many salivary gland tumors 
inevitably limits the accuracy of FNB due to the small size and selective 
character of the sample 
 Diagnosis of pleomorphic adenoma and warthins tumour are easy 
 False negative results are related to cystic tumours, warthins 
tumour, mucoepidermoidcarcinoma,acinic cell carcinoma etc. 
 False positive results are related to regenerative epithelial 
hyperplasia and squamous metaplasia in sialadinitis or warthinstumour. 
 Hyaline globules in monomorphic adenoma are misdiagnosed as 
adenoid cystic carcinoma 
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 The distinction between primary and metastatic carcinoma is 
difficult in poorly differentiated carcinoma 
DISORDERS OF SALIVARY GLANDS 
These are four main salivary glands and multiple minor salivary 
glands. 
PAROTID TUMOURS36: 
• Most common is pleomorphic adenoma (80-89%) 
• Low grade malignant tumours cannot be distinguished 
from benign neoplasms 
• High grade tumors grow rapidly are usually painful 
and often have lymph node involvement at 
presentation 
• CT and MRI are useful 
• Open biopsy is avoided, so FNAC is the preferred 
investigation 
• Tumors should be excised, enucleated 
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CLASSIFICATION36 
 
TYPE SUBGROUP EXAMPLES 
1. Adenoma 
Pleomorphic 
 
Monomorphic 
Pleomorphic adenoma 
 
Warthinstumour 
2. Carcinoma Low grade 
Acinic cell carcinoma 
 
Adenoid cystic carcinoma 
 
Low grade mucoepidermoid 
 
Carcinoma 
 High grade 
Adenocarcinoma 
 
Squamous cell carcinoma 
 
High grade mucoepidermoid 
 
carcinoma 
3. Non epithelial tumors  Hemangioma Lymphangioma 
4. Lymphomas Primary Non Hodgkins 
 Secondary Lymphoma in Sjogren Syndrome 
5. Secondary tumors Local Distant 
Head and neck tumours 
Skin and bronchus 
6. Unclassified   
7. Tumor like lesions Solid 
Adeomatoid hyperplasia 
Benign lymphoepithelial 
Lesion 
 Cystic Salivary gland cysts 
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                      Pleomorphic Adenoma 
 
 
 
                   Mucoepidermoid carcinoma 
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TNM STAGING30 
Tumour: 
Tx- Primary tumour cannot be accessed 
T0-no evidence of primary tumour 
Tis-Carcinoma insitu 
T1-Tumours 2 cms or less without extraparenchymal extension. 
T2-Tumours 2cm-4cm without extra parenchymal extension. 
T3-Tumours having extraparenchymal extension without seventh 
nerve involvement and /or 4cm-6cm in greatest dimension 
T4-Tumours invade the base of skull, 7th nerve and/or >6cm. 
Node: 
Nx-Regional nodes cannot be assessed. 
N0-No regional node metastatic. 
N1-single ipsilateral node 3cm or less size 
N2- N2a-single ipsilateral 3-6cms size 
 N2b-multiple ipsilateral node no more than 6cm size. 
 N2c-Bilateral or contralateral lymph node no more than 6cm size 
N3-metastasis in lymph node >6cm size 
METASTASIS: 
Mx- Metastasis cannot be assessed 
M0- No distant metastatis 
M1- Distant metastasis.
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                            OBSERVATION AND RESULTS 
This study was conducted in 200 patients who presented to 
THANJAVUR MEDICAL COLLEGE AND HOSPITAL with various 
types of swellings. Out of these 200 patients, 40 were males and 160 were 
females. As there was more number of breast and thyroid swellings in the 
study, females outnumbered than males. 
The commonest causes of the breast lumps, presented here were, 
fibroadenoma  in case of benign swellings and Infiltrating ductal 
carcinoma among malignant varieties. In both the conditions FNAC & 
histopathological procedures done. The reports are found to be same in 
both procedures in most of the cases which is statistically evident. This is 
confirmed by using two way proportion Z test, the P values are 
calculated. So FNAC  is useful in diagnosing these two diseases.  
In fibroadenosis, FNAC reports are not conclusive needing further 
HPE for confirmatory diagnosis. There is no statistical correlation 
between the two reports calculated for fibroadenosis proving that HPE is 
needed to diagnose this swelling.  However Phyllodes tumour could be 
diagnosed with FNAC alone. 
Among the thyroid tumours for multinodular goiter and Papillary 
carcinoma of thyroid FNAC is conclusive which is statistically proved, so 
FNAC has more conclusive in diagnosing these thyroid diseases 
compared to histopathological examination. 
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In cases of follicular neoplasms, malignant features are diagnosed 
by histopathologically. 
 In adenomatous goiter P value is found to be significant so FNAC 
procedure is not much useful. So further HPE needed to confirm the 
diagnosis. 
In TB adenitis & in metastatic lymph node by using Two way 
proportion Z test P value for each condition was calculated and was found 
to be insignificant. So FNAC is the useful procedure in confirming these 
diseases. 
          In cases of the primary tumours of   lymph nodes where FNAC  
Procedures was done , the reports came as lymphoproliferative disorders. 
So  
Histopathological procedure is the ideal one in both confirmation and  
classification of these tumours  and the above is statistically proven.      
  In Reactive lymph adenitis   P values are calculated and it was 
found  
to be Insignificant, so FNAC is the diagnostic procedure in this lymph 
node  
disorders Compared to histopathological  examination    
     
 In partotid   gland tumours both benign & malignant tumour   
Conditions are  subjected to histopathological examination  & FNAC  
procedures. The FNAC results are same as that of HPE reports which is  
Statistically proved, so FNAC is conclusive in making the diagnosis   
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Obviating further HPE. 
In soft tissue tumours, FNAC was no difference with that of HPE 
in diagnosing Mesenchymal neoplasms was and lipoma. this is 
statistically proved.  P values for Malignant peripheral nerve sheath 
tumour  & in schwannoma were calculated and it was found to be 
insignificant..so FNAC is much useful to diagnose   MPNST & 
schwannoma 
One case reported as lymph cyst of thyroid turned out to be 
papillary carcinoma on histopathological examination. 
One case of the MNG was reported as Follicular neoplasm of 
thyroid in FNAC. 
          Three patients who were reported as nodular goiter in FNAC, 
found to be having Thyroiditis (Autoimmune) from the Histopathology 
reports 
             Less than 25 yrs   Females presented with fibroadenoma are  
Subjected to FNAC & histopathological examination, there is no much  
difference between FNAC and HPE  results.  
               In cases of lymphomas, for detecting the subtypes of Hodgkin’s  
& non Hodgkin’s and for immunohistochemistry, histopathological  
procedure is  needed. It is  not possible  with  FNAC to diagnose the  
subtypes of HL and NHL.  
             The    Diagnosis of the malignant neoplasm of soft tissues is   
confirmed by  trucut biopsy, so  FNAC  is not useful in diagnosis.  
 the limitation of this study; the results cannot be generalized 
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1.BREAST 
AGE ( Years)  FA Phylloides IDC 
10-20 22 - - 
21-30 10 1 4 
31-40 7 2 13 
41-50 - 1 9 
>50 - - 9 
 
2.THYROID 
AGE ( Years)       Adenoma MNG PTC 
10-20 - 2 - 
21-30 2 10 2 
31-40 - 10 3 
41-50 2 5 - 
>50 2 1 1 
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3. LYMPHNODE 
AGE ( Years) TB Lymphoma Metastasis 
<10 1 - - 
11-20 2 3 - 
21-30 3 2 - 
31-40 - 2 1 
41-50 - 2 1 
>50 - 4 2 
 
4. PAROTID  
Age Years Pleomorphic Adenoma Carcinoma 
10-20 - 1 
21-30 2 2 
31-40 - 2 
41-50 1 - 
>50 2 2 
 
BREAST DISEASES 
DISEASES FNAC
FA 47
IDC 33
Fibroadenosis 4
Fibrocystic 
Disease 
3
Phyllodes 4
Medullary Ca 0
Suppurative 
Lesion 
0
Tubular 
Adenoma 
0
Total 91
 
    
0
5
10
15
20
25
30
35
40
45
50
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 HPE P 
 40 0.786 
 33 1.00 
 8 0.059 
 4 0.699 
 6 0.515 
 2 0.155 
 1 0.316 
 1 0.316 
 91  
 
FNAC
HPE
 THYROID 
DISEASES 
MNG 
Adenomatous 
PCT 
Colloid 
Follicular 
Lymph Cyst 
Hashimoto/Autoimmune 
Thyroiditis 
Total 
 
 
0
5
10
15
20
25
30
75 
FNAC HPE P 
24 27 0.523
6 3 0.291
8 7 0.777
4 2 0.398
2 2 1.000
1 0 0.314
0 4 0.040
45 45  
 
 
 
 
 
 
 
 
FNAC
HPE
  
 LYMPH NODE SWELLINGS
   DISEASES 
Lymphoproliferative/HL
Tb Adenitis 
Reactive 
Metastatic 
Infected Cyst Neck/Bronchial Cyst
Total 
 
 
 
11
12
76 
 
FNAC HPE P 
/NHL 11 12 0.783
8 9 0.769
5 3 0.443
2 2 1.00
 1 1 1.00
27 27  
8
5
2
9
3
2
LYMPH NODE
FNAC HPE
 
 
 
 
 
 
1 1
     SALIVARY GLAND
DISEASES 
Pleomorphic 
Monomorphic 
Mucoepidermoid 
Ca 
Chronic 
Sialadinitis 
Acinic Cell Ca 
Total 
 
     
 
 
10
9
0
2
4
6
8
10
12
77 
 SWELLINGS 
FNAC HPE P 
10 9 0.803 
1 1 1.00 
3 3 0.418 
3 3 1.00 
0 1 0.31 
17 17  
1
3 3
0
1
3 3
FNAC HPE
 
1
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  SOFT TISSUE SWELLINGS 
   DISEASES FNAC  HPE      P 
Lipoma 9 9 1.00 
Mesenchymal 8 6 0.036 
MPNST 1 1 1.00 
Schwannoma 2 2 1.00 
Total 20 20  
   
 
 
    
 
  
0
1
2
3
4
5
6
7
8
9
10
LIPOMA MESENCHYMAL MPNST SCHWANNOMA
FNAC
HPE
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DISCUSSION 
The incidence of breast cancer in India is increasing now days and 
approaching to that in the western world. The incidence of early detection 
of breast cancer is increasing dramatically due to public awareness and 
widespread use of mammography. However, no significant decrease in 
mortality from breast cancer has yet been noted. 
The literature sensitivity in the diagnosis of carcinoma breast was 
90-95%. In our study it was proved and almost matches the literature 
sensitivity. The commonest benign swelling of the breast, fibroadenoma, 
is also diagnosed by FNAC and statistically proved. 
Ashcroft & Von Henle achieved a diagnosis of thyroid neoplasm in 
the accuracy of over 90%. Papillary thyroid carcinoma had an accuracy of 
80% in the study. 
In lymphnode swellings, role of FNAC in diagnosing lymphoma, 
Tuberculosis, and metastatic node is much important, which is 
statistically proved in our study, this almost approaches the recommended 
value from other studies of 84-98% for lymphoma and 90-96% for 
metastasis. The study conducted at PGI, Chandigarh showed sensitivity 
for lymphoma, TB & metastasis as 64.8%, 60.5% and 71.6% 
respectively. 
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Karolinska produced accuracy of more than 90% in neoplasm’s of 
salivary glands. In 1994 reviews, they produced sensitivity of 81-100% 
and accuracy of typing in 61-80%. Our study results also proves same 
that of literature results  
The reported sensitivity of 100% lipoma, 82% for mesenchymal 
malignancy in this study differs a little from the literature results of 86% 
for benign and 88% for malignant soft tissue tumours. 
The lesser sensitivity of FNAC for the diagnosis of fibroadenosis is 
due to the variable responsiveness of the breast tissue portions to 
hormonal stimuli and cytology taken from unresponsive fibrous portions 
The false positivity in case of papillary carcinoma and Follicular 
carcinoma I MNG may be due to papillary and follicular pattern observed 
in the follicle lining epithelium, while they are in a transforming state of 
non-toxic to toxic. This can be minimized by careful study cytology. 
Lymphomas would not be typed from FNAC, even though it is 
reported as lymphoproliferative disorder. So it would be better to go for 
excision biopsy if lymphoma is suspected. 
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CONCLUSION 
1. FNAC is highly sensitive in diagnosing neoplasms of breast, 
Thyroid and Parotid. 
2. Lymphomas can be found out by FNAC but typing of 
Lymphoma needs excision biopsy. 
3. Benign swelling of the breast ( Fibroadenoma ), Parotid ( 
Pleomorphic Adenoma ), soft tissue ( lipoma ) can be diagnosed 
with high accuracy by FNAC. 
4. FNAC is useful in conjunction with clinical radiological 
findings to provide best possible initial assessment. 
5. The diagnostic accuracy not only depends on responsiveness of 
the aspirate but also on the quality of cytological preparation. 
6. Repeat FNAC sampling over a period of time reduces the false 
negative rates.    
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ANNEXURES 
 
1. STATISTICAL DATA 
BREAST DISEASES  
DISEASES FNAC HPE P 
FA 47 40 0.786 
IDC 33 33 1.00 
Fibroadenosis 4 8 0.059 
Fibrocystic 
Disease 
3 4 0.699 
Phyllodes 4 6 0.515 
Medullary Ca 0 2 0.155 
Suppurative 
Lesion 
0 1 0.316 
Tubular Adenoma 0 1 0.316 
Total 91 91  
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THYROID DISEASES 
DISEASES FNAC HPE P 
MNG 24 27 0.523 
Adenomatous 6 3 0.291 
PCT 8 7 0.777 
Colloid 4 2 0.398 
Follicular 2 2 1.000 
Lymph Cyst 1 0 0.314 
Hashimoto/Autoimmune 
Thyroiditis 
0 4 0.040 
Total 45 45  
 
LYMPH NODE DISEASES 
DISEASES FNAC HPE P 
Lymphoproliferative/HL/NHL 11 12 0.783 
Tb Adenitis 8 9 0.769 
Reactive 5 3 0.443 
Metastatic 2 2 1.00 
Infected Cyst Neck/Bronchial Cyst 1 1 1.00 
Total 27 27  
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SALIVARY GLAND DISORDERS 
DISEASES FNAC HPE P 
Pleomorphic 10 9 0.803 
Monomorphic 1 1 1.00 
Mucoepidermoid Ca 3 3 0.418 
Chronic Sialadinitis 3 3 1.00 
Acinic Cell Ca 0 1 0.31 
Total 17 17  
 
SOFT TISSUE SWELLINGS 
DISEASES FNAC  HPE      P 
Lipoma 9 9 1.00 
Mesenchymal 8 6 0.036 
MPNST  1 1 1.00 
Schwannoma 2 2 1.00 
Total 20 20  
 
P<0.05 is significant – it means FNAC is not USEFUL to detect 
that particular pathology,HPE correlation is necessaray 
Statistic – Two way proportion Z test 
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specimen1 * common Crosstabulation 
   common 
Total    0 1 
specimen1 B
R
E
A
S
T
Count 65 27 92 
% within specimen1 70.7% 29.3% 100.0% 
% within common 54.2% 33.8% 46.0% 
% of Total 
32.5% 13.5% 46.0% 
L
Y
M
P
H
N
Count 10 17 27 
% within specimen1 37.0% 63.0% 100.0% 
% within common 8.3% 21.2% 13.5% 
% of Total 
5.0% 8.5% 13.5% 
S
A
L
I
V
A
Count 11 6 17 
% within specimen1 64.7% 35.3% 100.0% 
% within common 9.2% 7.5% 8.5% 
% of Total 
5.5% 3.0% 8.5% 
S
O
F
T
 
T
Count 11 9 20 
% within specimen1 55.0% 45.0% 100.0% 
% within common 9.2% 11.2% 10.0% 
% of Total 
5.5% 4.5% 10.0% 
T
H
Y
Count 23 21 44 
% within specimen1 52.3% 47.7% 100.0% 
% within common 19.2% 26.2% 22.0% 
specimen1 both preliminary and confirmative test proved positive (a) 
both preliminary and confirmative 
test proved negative (b) Total 
BREAST 65 27 92 
LYMPHN 10 17 27 
SALIVA 11 6 17 
SOFT T 11 9 20 
THYROI 23 21 44 
 
120 80 200 
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R
O
I
% of Total 
11.5% 10.5% 22.0% 
Total Count 120 80 200 
% within specimen1 60.0% 40.0% 100.0% 
% within common 100.0% 100.0% 100.0% 
% of Total 60.0% 40.0% 100.0% 
 
 
The above table clearly says the percentage of tests conducted proved both positive 
and one negative. 
 
 
 
Chi-Square Tests 
 
Value df 
Asymp. Sig. (2-
sided) 
Pearson Chi-Square 11.742a 4 .019 
Likelihood Ratio 11.741 4 .019 
Linear-by-Linear Association 3.464 1 .063 
N of Valid Cases 200   
a. 0 cells (.0%) have expected count less than 5. The minimum 
expected count is 6.80. 
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                                            PROFORMA 
 
 
Name:                IP No: 
 
 
Age:  
 
 
 
PRESENTING COMPLAINTS 
 
 
 
PAST HISTORY 
 
 
Surgeries 
 
Medical conditions: Diabetes/Hypertension/Tuberculosis/Asthma. 
 
 
FAMILY HISTORY 
 
PERSONAL HISTORY 
 
Diet Sleep 
 
Bowel habits. Smoker/Alcoholic 
 
 
EXAMINATION 
 
GENERAL EXAMINATION: 
 
Pallor Icterus 
 
Cyanosis Clubbing 
 
Lymphadenopathy 
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Vitals: Pulse rate: Blood pressure: 
 
SYSTEMIC EXAMINATION 
 
Per abdomen 
 
Cardiovascular System: 
 
Respiratory System: 
 
Central Nervous System: 
 
LOCAL EXAMINATION 
 
Per rectal: rectal deposits 
 
DIAGNOSIS: 
 
 
INVESTIGATIONS 
 
Hb%, TC: DC: ESR: RBS: Blood urea: 
 
Serum creatinine: BT: CT: Chest x-ray: ECG, Bleeding time, clotting 
time. 
 
Serum PSA,X-pelvis and lumbar vertebrae. USG-abdomen and pelvis. 
 
 
 
 
PRE FNAC PREPARATION: 
 
                      Clean the area with sprit    
 
POST OP HPE report 
 
REGULLAR FOLLOW UP OF THE PATIENT. 
 
   Sl. No. NAME AGE/SEX 
IP. 
NUMBER UNIT FNAC HPE 
1. Sathyapriya 20/F 1382415 S3 FA FA 
2. Ishath Begum 50/F 13821 S3 IDC IDC 
3. Ramya 20/F 43215 S3 FA FA 
4. Valaramathi 30/F 1342955 S5 PTC PTC 
5. Sheela 37/F 1384449 S1 Nodular goiter MNG 
6. Saleemabeevi 60/F 1377520 S4 IDC IDC 
7. Inbarasi 55/F 1383990 S4 Nodular goiter Hashimatos 
8. Srimathi 45/F 1381018 S4 IDC IDC 
9. Mallika 30/F 1383863 S4 SNG MNG 
10. Banumathy 35/F 1383823 S4 Fibrocystic mastopathy Suppurative lesion 
11. Ilamathi 60/F 1383343 S1 Dominant nodule of MNG MNG with Adenomatous nodule 
12. Prabha 22/F 1312456 S1 FA FA 
13. Shanthi 50/F 1378980 S1 MNG MNG 
14. Kousalya 35/F 1384479 S1 Follicular neoplasm MNG 
15. Vanmathi 14/F 1368868 S1 Fibroadenoma FA 
16. Devaki 39/F 1385859 S4 MNG MNG 
17. Anjammal 32/F 1354722 S1 Fibroadenosis Fibroadenosis 
18. Tamilarasi 26/F 1388697 S2 Follicular neoplasm MNG 
19. Kannagi 52/F 1383231 S4 IDC IDC 
20. Indra 36/F 1387148 S2 Colloid goiter Simple goitre 
  
21. Kaliyan 46/M 1398993 S1 PTC PTC 
22. Poongadi 46/F 13949094 S3 Cystic degeneration in nodular 
goiter 
MNG 
23. Radha 30/F 1387541 S1 FA BnPhillodes 
24. Vembu 28/F 1323675 S3 FA FA 
25. Priya 18/F 1387630 S1 FA FA 
26. Janaki 30/F 1386231 S1 Fibroadenosis IDC 
27. Rahasathnisha 27/F 1327562 S2 FA Fibrocystic mastopathy 
28. Nagarathinam 35/F 1301682 S3 Colloid nodule MNG 
.29. Rani 22/F 1328541 S3 FA FA 
30. Aramauthai 35/F 1330608 S2 FA Fibro adenosis 
31. Revathi 35/F 1331905 S3 Nodular goiter Mng 
32. Mayammal 55/F 1334534 S5 FA Fibrocyticmastopathy 
33. Susheela 45/F 1334750 S6 IDC IDC 
34. Dhanalakshmi 65/F 1335101 S2 Nodular goiter MNG 
35. Tamilarasi 40/F 1333874 S1 NODULAR GOITER HASHIMATOS 
36. Pushpavalli 38/F 1335720 S5 FA FIBROCYSTIC 
MASTOPATHY 
37. Veerammal 55/F 1394113 S4 Ductal carcinoma IDC 
38. Manjula 45/F 1395685 S6 IDC IDC 
39. Selvi 24/F 1394121 S4 FA FA 
40. Uthirapathi 32/M 1396354 S3 Nodule of MNG MNG 
  
 
 
 
 
 
 
 
 
 
 
 
  
41. Sumathi 23/F 1105325 S1 PTC PTC 
42. Rajeshwari 53/F 1399297 S4 IDC IDC 
43. Saroja 20/F 1399366 S4 FA FA 
44. Geetha 29/F 1325401 S1 PTC PTC 
45. Selvarani 34/F 1327386 S4 FA Fibroadenosis 
46. Pushpam 65/F 1339703 S1 FA Fibroadenosis 
47. Meenambal 65/F 1338978 S4 Fibroadenosis Fibroadenosis 
48. Sumathi 34/F 1342893 S5 Nodular goiter MNG 
49. Dhavath Begum 45/F 1345336 S1 Nodular goiter MNG 
50. Neelavathy 50/F 1344967 S2 FA FA 
51. Reyeesbeevi 53/F 1343876 S6 IDC IDC 
52. Pushpam 65/F 1356863 S2 Nodular goiter Autoimmune thyroiditis 
53. Malarkodi 33/F 1382721 S5 Adenomatous goiter Mng 
54. Rajalakshmi 37/F 1350746 S1 IDC IDC 
55. Arumbu 47/F 1329490 S2 FA FA 
56. Kavitha 29/F 1329585 S3 Cystosarcomaphyllodes Malignant phyllodes 
57. Amala 45/F 1331143 S5 IDC IDC 
58. Chithra 20/F 1333627 S5 FA FA 
59. Shanthi 35/F 1332921 S5 IDC Medullayca 
60. Uma 35/F 1333444 S3 FA Benign phllodes 
  
61. Magamayee 45/F 1389444 S6 Cystosarcomaphyllodes Malignant phyllodes 
62. Muthulakshmi 48/F 1391633 S4 IDC IDC-NOS 
63. Usharani 28/F 1392900 S1 FA FA 
64. Kasthuri 25/F 1391582 S3 FA FA 
65. Muthulakshmi 40/F 1391638 S3 FA FA 
66. Pushpavalli 42/F 1396195 S5 COLLLOID GOITER Simple colloid goiter 
67. Mariyathal 18/F 1399300 S4 FA FA 
68. Revathy 30/F 1399006 S5 Fibroadenosis FA 
69. Chinnapillai 52/F 1236121 S5 IDC IDC –NOS 
70. Sundari 36/F 1326799 S4 IDC IDC 
71. Jayalakshmi 62/F 1328211 S2 FA Fibroadenosis 
72. Jothi 37/F 1382640 S4 Phyllodetumour Invasive papillary ca 
73. Ilamathi 18/F 1383343 S1 FA FA 
74. Seethamani 35/F 1384745 S5 IDC IDC NOS 
75. Jaminaparveen 49/F 1388816 S3 Nodular goiter hashimatos 
76. Kavitha 35/F 1388728 S5 FA FA 
77. Sudha 13/F 1388683 S1 FA FA 
78. Sandhya 14/F 1388833 S5 FA FIBROADENOSIS 
79. Rosi 25/F 1388335 S1 Adenomatous goiter Adenomatous goiter 
80. Jasmine 19/F 138895 S1 FA fibroadenosis 
81 vanathi 32/f 1387856 S2 Pleomorphic adenoma Lowgrade mucoepidermoid ca 
82 Jegadeesan 48/m 1387878 S4 schwanoma Schwanoma 
83 padmanabhan 40/m 1377556 S1 Chronic sialadinitis Chronic sialadinitis 
84 Senthamarai 
kannan  
15/m 1389735 S1 HL HL- lymphocytic predominant 
85 sathyabama 45/f 1387624 S6 Pleomorphic adenoma Pleomorphic adenoma 
86 Sundarambal 45/f 1387748 S6 Lymphoproliferative 
disorder 
HL 
87 Rajendran 26/m 1387679 S3 TB adenitis TB adenitis 
88 Jegatheesan 
 
15/m 1383267 S1 Lowgrade mucoepidermoid 
carcinoma 
Lowgrade mucoepidermoid 
carcinoma 
89 MuTHAMILSELVI 29/F 1382345 S3 Lymphoproliferative 
disorder 
HL 
90 REKHA 20/m 1303134 S3 Lymphoproliferative 
disorder 
HL 
91 Sarojini 28/f 1342523 S6 Myoepithelial rich 
pleomorphic adenoma 
Acinic cell carcinoma 
92 Pariventhan 4/m 1325624 S1 Infected cyst neck Bronchial cyst 
93 Rosemary 50/f 1391298 S1 Nodular goiter MNG 
94 Sathiya 30/m 1324878 RT Pleomorphic MFH Pleomorphic variant of RMS 
95 Silambarasi 32/f 1346807 S4 IDC IDC 
96 Latha 24/f 1324521 S5 FA FA 
97 Muthukrishnan 29/m 1324562 S2 PCT PCT 
98 Papathi 30/f 1324556 S6 nodule of the nodular goiter Adenomatous goiter 
99 Tamilarasi 30/f 1324566 S3 IDC IDC 
100 Vijayasankar 47/m 1345261 S6 Pleomorphic adenoma Pleomorphic adenoma 
 101 Sakila 16/f 1324512 S5 FA FA 
102 Kasiammal 55/f 1324563 S3 IDC IDC-NOS 
103 Nagammal 60/f 1324156 S1 IDC IDC-NOS 
104 Maruthavani 55/f 1342513 S3 Adenoma thyroid Follicular adenoma 
105 Amsu 35/f 1345262 S5 IDC IDC-NOS 
106 Anjalai 60/f 1324783 S4 IDC IDC-NOS 
107 Rajendran 40/M 1324566 S3 Lymphcyst thyroid PCT 
108 Selvi 24/f 1325647 S5 Nodular goiter MNG 
109 Venkatachalam 53/m 1324561 S4 Reactive adenitis HL-lymphocytic predominant 
110 Suseela 40/f 1342561 S3 Fibrocystic disease 
atypical hyperplasia 
FA 
111 Sudha Rani 18/f 1345627 S5 FA FA 
112 Ulaganathan 40/m 1324456 S2 Lipoma(cervical 
region) 
Lipoma 
113 Manjula 25/f 1324536 S2 FA FA 
114 Soundaraj 50/m 1324516 S1 Lymphoprolifertive 
changes 
NHL 
115 Latha 19/f 1324574 S6 FA Fibroadenosis 
116 Indirani 50/f 1324563  S3 IDC IDC with fibrocystic changes 
117 Kaladevi 25/f 1324567 S4 Nodule of the nodular 
goiter 
MNG 
118 Chellamuthu 40/f 1324513 S6 Lipoma Lipoma 
119 Papu 45/f 1324561 S5 Adenomatous goiter Adenomatous goiter 
120 Parvathy 27/f 1367288 S5 PCT MNG 
 
 121 Narayanasamy 55/m 1344343 S2 Lipoma neck lipoma 
122 Palanivel 56/m 1328945 S3 HL HL-lymphocyte 
predominant 
123 Muniyandi 58/m 1324589 S4 Lymphoproliferative 
disorder 
NHL 
124 Kanimozhi 26/f 1324561 S4 FA fibroadenosis 
125 Suganthi 17/f 1324676 S4 FA FA 
126 Ayyasami 40/M 1324243 S1 Pleomorphic population of 
lymphocytes 
Caseating TB adenitis 
127 Ponni 33/f  1324554 S2 IDC IDC 
128 Selvi 33/f 1326784 S3 IDC IDC-NOS 
129 Menaka 23/f 1324523 S6 FA Tubular adenoma of the 
breast 
130 Vijaya 40/f 1324425 S3 Nodular goiter MNG 
131 Amirtha 34/f 1342215 S5 Phylloidestumour Malignant phyllodes 
132 Bharathy 30/m 1345263 S3 NODULAR GOITER MNG with secondary 
features of haemorrhage 
133 Rani 27/f 1324529 S5 Nodular goiter MNG 
134 Vasantha 57/f 1324523 S3 MFH Sarcomatous growth 
135 Ramakrishnan 18/m 1324567 S4 Lymphoproliferative 
disorder 
HL-lymphocytic 
predominant 
136 Hathija Begam 40/f 1324677 S4 Fibrocystic disease IDC 
137 Valliammai 45/f 1324688 S4 IDC IDC 
138 Rajalaksmi 38/f 1345887 S5 Nodular goiter Nodule of the nodular goiter 
139 Vasanthi 40/f 1324561 S3 IDC IDC 
140 Selvanathan 18/m 1345627 S4 Granulomatous adenitis TB adenitis 
 
 
141 Nirmala 30/f 1324562 S2 Chronic sialadinitis Chronic sialadinitis 
142 Ramaselvi 62/f 1345627 S1 Pleomorphic adenoma Pleomorphic adenoma 
143 Chellammal 40/f 1324562 S4 Metastatic 
adenocarcinoma 
Metastatic SCC 
144 Parvathy 30/f 1342561 S5 Chronic Granulomatous 
lymphadenitis 
TB adenitis 
145 Parthiban 35/m 1324562 S4 Pleomorphic adenoma Pleomorphic adenoma 
146 Jeya 33/f 1234256 S1 Granulomatous 
lymphadenitis 
Caseating TB adenitis 
147 Subathra 35/f 1325643 S5 Reactive adenitis TB adenitis 
148 Thangavel 60/m 1346578 S4 High grade 
Mucoepidermoidca 
High grade Mucoepidermoidca 
149 Wahithabegam 32/f 1387822 S2 Pleomorphic adenoma Lowgrademucoepidermoidca 
150 Chidambaram 48/m 1387848 S4 schwanoma Schwanoma 
151 Natarajan 40/m 1377510 S1 Chronic sialadinitis Chronic sialadinitis 
152 Surichandran 15/m 1389786 S1 HL HL- lymphocytic predominant 
153 Bhuvaneswari 45/f 1387604 S6 Pleomorphic adenoma Pleomorphic adenoma 
154 Gnanasunder 8/m 1387793 S6 Granulomatous 
lymphadenitis 
Caseating TB adenitis 
155 Malligabegam 45/f 1387696 S3 Reactive hyperplasia Reactive hyperplasia 
156 Vanitharani 24/f 1384646 S1 Lipoma Lipoma 
157 Martin 39/m 1386978 S3 Low grade MPNST Low grade MPNST 
158 Eswari 13/f 1339698 S1 Lipoma Lipoma 
159 Logambal 70/f 1387601 S5 Monomorphic adenoma Pleomorphic adenoma 
160 Radhika 25/f 1389765 S2 Granulomatous adenitis Tuberculous adenitis 
 
 
 
 161 Marimuthu 70/m 1388755 S3 Pleomorphic adenoma Monomorphic adenoma 
162 Thangaraj 45/m 1333938 S1 Lipoma(arm) Lipoma 
163 Dhanaraj 42/m 1387657 S4 Pleomorphic adenoma Pleomorphic adenoma 
164 Jegatheesan 25/m 1388732 S3 Lymphoproliferativa disorder HL 
165 Selvaraj 
 
65/m 1383208 S1 GCT-seminoma Embryonalrhabdomyosarcoma 
166 Murugan 50/m  1382308 S3 Lipoma Lipoma 
167 Devaraj 20/m 1303106 S3 Dermoid CALCFIED PILLAR CYST 
168 Rajangam 54/m 1342561 MGE  HCC ADENOCARCINOMATOUS 
DEPOSITS 
169 Vidivelli 45/f 1367543 S5 Lipoma both axilla Lipoma 
170 Nallamal 35/F 1324532 S5 Lipoma both axilla Lipoma 
171 Settu 40/m 1325632 S5 Metastatic deposits Metastatic SCC 
172 Jeyamary 56/f 1325698 S6 Reactive hyperplasia Reactive hyperplasia 
173 Pattamal 70/f 1345678 S5 Mucoepidermoidca High grade Mucoepidermoidca 
174 Kumari 58/f 1356789 S6 Mesenchymal neoplasm MaligMesenchymal neoplasm 
175 Ramayee 40/f 1387055 S3  Basal cell adenoma Basal cell adenoma 
176 Muthulakashmi 9/f 1324567 S5 Reactive adenitis  Reactive adenitis 
177 Kasinathan 60/m 1387654 S4 Lymphoproliferative HL 
178 Bhuvaneswari 24/f 1386758 PS  Post auricular dermoid Lymph cyst 
179 Jeganathan 65/m 1386645 S5 Mesenchymal neoplasm Malignant PNST 
180 Saritha 20/f 1390034 S3  FA FA 
 
  
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
181 Jothi 20/f 1387765 S3 IDC IDC 
182 Vellaiammal 37/f 1389876 S2 IDC IDC 
183 Anjammal 37/f 1382349 S1 FA FA 
184 Sowharnsha 38/f 1388987 S4 Nodular goiter Nodule of nodular goiter 
185 Vasavi 18/f 1389007 S2 FA FIBROCYSTIC 
MASTOPATHY 
186 Sasikala 18/f 1388945 S4 FA FA 
187 Vijaya  37/f 1388907 S5 PTC PTC 
188 Saranya 18/f 1388951 S1 FA FA 
189 Poongothai 24/f 1388812 S4 Nodular colloid goitre MNG 
190 Malarvizhi 18/f 1388925 S6 FA FA 
191 Sellamarai 23/f 1390129 S1 Adenomatous goiter MNG 
192 Selvi 24/f 1390001 S2 IDC IDC-NOS 
193 Krishnaveni 20/f 1390082 S2 FA FA 
194 Visalatchi 45/f 1390034 S1 IDC IDC-NOS 
195 Vasantha 40/f 1388888 S2 IDC IDC-NOS 
196 Jasmine 19/f 1388955 S1 FA FA 
197 Senthamarai 60/f 1388896 S3 IDC IDC-NOS 
198 Sahayamary 43/f 1388937 S2 PCT MNG 
199 Rosi 18/f 1388868 S1 FA fibroadenosis 
200 Santhya 17/f 1388833 S5 FA FA 
  
 
PTC-Papillary Thyroid Carcinoma, MNG-Multinodular Goiter,           FA-Fibroadenoma 
,IDC-NOS-Intraductalcarcinoma,  Nothing Otherwise Specified,  
ADH-Atypical Ductal Hyperplasia, 
HL-Hodgekins Lymphoma, MPNST-Malignant Peripheral Nerve Sheath Tumour 
NHL- Non Hodgkins Lymphoma 
FNAC-Fine Needle Aspiration Cytology, HPE-Histopathological Examination 
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